CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer

NCT00017017 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: paclitaxel poliglumex

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]